CYTEK BIOSCIENCES, INC. Effective Income Tax Rate Reconciliation, Deduction, Percent
CYTEK BIOSCIENCES, INC. (CTKB) reported Effective Income Tax Rate Reconciliation, Deduction, Percent of 39.20% for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-01.
Discontinued › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationDeductions · last filed 2023-03-01
- CYTEK BIOSCIENCES, INC. effective income tax rate reconciliation, deduction, percent for fiscal 2022 was 39.20%, a 905.13% increase from fiscal 2021.
- CYTEK BIOSCIENCES, INC. effective income tax rate reconciliation, deduction, percent for fiscal 2021 was 3.90%, a 160.00% increase from fiscal 2020.
- CYTEK BIOSCIENCES, INC. effective income tax rate reconciliation, deduction, percent for fiscal 2020 was 1.50%.
| Period end | Effective Income Tax Rate Reconciliation, Deduction, Percent 12 month |
|---|---|
| 2022-12-31 | 39.20% 10-K · filed 2023-03-01 |
| 2021-12-31 | 3.90% 10-K · filed 2023-03-01 |
| 2020-12-31 | 1.50% 10-K · filed 2023-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B |